Pharmaffiliates Analytics & Synthetics (P) Ltd, operates as an integrated CRDO (Contract Research and Development Organization). The facility has undergone auditing and acceptance by US-FDA, and has obtained ISO 17034, ISO 17025 & ISO 9001 Certifications. The company specializes in conducting research through the synthesis of intricate and challenging compounds such as impurities, metabolites, NCEs, and intermediates. Additionally, it conducts principal development to commercial scale-up, and innovates and develops organic molecules to support and expedite drug discovery research for pharmaceutical and biotech companies.